Shikeagi Kato, an endocrinology researcher who resigned from the University of Tokyo in March 2012 amid an investigation that concluded 43 of his papers should be retracted, has retracted five more papers.
The newest is in this week’s Nature, for “GlcNAcylation of a histone methyltransferase in retinoic-acid-induced granulopoiesis,” a paper first published in 2009. Here’s the notice: Continue reading Shigeaki Kato notches five more retractions, including one in Nature
It’s really hard to get papers retracted, police might be best-equipped to handle scientific misconduct investigations, and there’s finally software that will identify likely image manipulation.
Those are three highlights from a number of pieces that have appeared in Nature and Nature Medicine in the past few weeks. Not surprisingly, there are common threads, so join us as we follow the bouncing ball. Continue reading Should scientific misconduct be handled by the police? It’s fraud week at Nature and Nature Medicine
Nearly six months after first expressing concern about the validity of a 2010 paper on multiple sclerosis, Nature Medicine has retracted the article for containing “erroneous” data — which in this case don’t seem to have existed, making them more fabricated than wrong.
The paper, “Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease,” came from a group led by Jingwu Zhang, who at the time ran GlaxoSmithKline’s Research and Development Center in Shanghai.
In June, the journal issued an expression of concern about the article after readers discovered problems with the data, as reported by Nature Medicine’s blog.
Continue reading Nature Medicine retracts MS paper with ghost data by former GSK researcher
A 2005 Nature study that has vexed one of its authors since 2007 is finally being retracted.
The notice for “Dance reveals symmetry especially in young men,” by William M. Brown, Lee Cronk, Keith Grochow, Amy Jacobson, C. Karen Liu, Zoran Popovic´& Robert Trivers, says very little: Continue reading At long last, disputed dance study retracted from Nature
A group of researchers in Ireland has retracted their 2013 article on a possible new method for treating amyotrophic lateral sclerosis — ALS, also commonly called Lou Gehrig’s disease — after identifying errors in several images in the paper.
The article, “Acidotoxicity and acid-sensing ion channels contribute to motoneuron degeneration,” was published online in Cell Death & Differentiation (and appeared in the April 1 print issue, although we think that was a coincidence…). Continue reading ALS paper retracted for figure problems
Nature has retracted a controversial 2012 paper by a group from Johns Hopkins University which has been the subject of a protracted public dispute.
The article, “Functional dissection of lysine deacetylases reveals that HDAC1 and p300 regulate AMPK,” came from the lab of Jef Boeke, a celebrated biochemist. But a former lab member, Daniel Yuan, who was fired by Hopkins in late 2011 after 10 years at the institution, had repeatedly raised questions about the validity of the findings. Those concerns eventually made their way into the Washington Post, prompting this response from the university. Continue reading Nature yanks controversial genetics paper whose co-author was found dead in lab in 2012
We tend to stick to retractions in the peer-reviewed literature here at Retraction Watch, although we’ve made exceptions. Today’s post seemed like a good reason to make another exception, because while Nature Publishing Group-owned Scientific American is not a peer-reviewed journal, the science blogosphere and Twitter are lighting up this weekend with strong reactions to the magazine’s removal of a blog post by biologist Danielle Lee.
The incident was first noted by Dr. Rubidium, who wrote yesterday:
Scientist and science communicator @DNLee5 declined an offer to blog for free from biology-online.org and got called a ‘whore’. @DNLee5 posted a thoughtful response on her Scientific American‘s blog ’The Urban Scientist‘. A short time later, her response vanished…
(You can read Lee’s original post on Dr. Isis’s blog.)
Yesterday morning, Scientific American editor-in-chief Mariette DiChristina responded on Twitter: Continue reading Scientific American faces firestorm after removing blog post about scientist being called a whore
Two of three authors in Argentina of a 2002 paper purporting to show evidence of bird-like fossil footprints from the Late Triassic age have retracted it after subsequent research suggested their estimates were off.
Here’s the notice for “Bird-like fossil footprints from the Late Triassic:” Continue reading Authors retract Nature paper on bird-like footprints thought to date to Late Triassic
We’ve often found that when some authors refuse to sign retraction notices, there’s a much bigger story than terse notices let on. And a retraction in this week’s Nature of a 19-year-old paper is a shining example of that.
Here’s the brief notice for “Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity,” a 1994 paper by researchers from the UK and the Czech Republic that had already been subject to a 1996 correction: Continue reading Retraction of 19-year-old Nature paper reveals hidden cameras, lab break-in, evidence tampering
Last month, Ivan met David Vaux at the 3rd World Conference on Research Integrity in Montreal. David mentioned a retraction he published in Nature, and we thought it would be a great guest post on what it’s like to retract one of your own papers in an attempt to clean up the literature.
In September 1995 Nature asked me to review a manuscript by Bellgrau and co-workers, which subsequently appeared. I was very excited by this paper, as it showed that expression of CD95L on Sertoli cells in allogeneic mismatched testes tissue transplanted under the kidney capsule was able to induce apoptosis of invading cytotoxic T cells, thereby preventing rejection. As I wrote in a News and Views piece, the implications of these findings were enormous – grafts engineered to express CD95L would be able to prevent rejection without generalized immunosuppression.
In fact, I was so taken by these findings that we started generation of transgenic mice that expressed CD95L on their islet beta cells to see if it would allow islet cell grafts to avoid rejection and provide a cure for diabetes in mismatched recipients.
Little did we know that instead of providing an answer to transplant rejection, these experiments would teach us a great deal about editorial practices and the difficulty of correcting errors once they appear in the literature. Continue reading Why I retracted my Nature paper: A guest post from David Vaux about correcting the scientific record